FDA Investigator Constance Desimone

Constance Desimone has conducted inspections on 92 sites in 1 countries as of 30 Oct 2006. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
92
Last Inspection Date:
30 Oct 2006
Investigator Role:
FDA Investigation Participant
Redica ID:
100001903
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Constance Desimone:
Abby E Pelletier, Abdur Rafay Shareef, Aireen V Mendoza, Alan R Condon, Alice C Silva, Alice Canty, Almaris N Alonso, Amber G Wardwell, Amy C Jordan, Andrew M Barlow, Anthony C Warchut, Anthony N Onianwa, Anthony W Thomas, Asia D Clark, Barbara G Swan, Brenda P King, Charisse K Green, Christine L Williams, Courtney N Long, Daniel L Zheng, Darin S Wiegers, Daryl A Dewoskin, David P Vanhouten, Dawn M Braswell, Dien N Nguyen, Dr. Sriram Subramaniam, PhD, Edmund F Mrak, Jr, Elizabeth B Griffin, Ellen P Madigan, Erin P Conlin, Felix Maldonado, Gamal A Norton, Garry H Stewart, Gary J Hagan, George M Ibrahim, George T Allen, Jr, Gerard D Difiore, Hien Albright, James W Whitney, Jawaid Hamid, John P Mistler, John S Hartford, Jonathan G Matrisciano, Jose A Torres, Jose M Cayuela, Justine M Corson, Karen Mcnabb Noon, Kathleen E Mcafoose, Kenneth H Williams, Kent A Conforti, Kristina J Donohue, Kristina M Joyce, Laura L Staples, Laurie B Frazier, LCDR Debra Emerson, Leo B Zadecky, Lori M Newman, Louis Christy, Margaret E Walsh, Mark A Heard, Mark C Lookabaugh, Mark E Parmon, Mark R Mcclain, Martin J Guardia, Mary Jeanet Mcgarry, Matthew C Watson, Maura Rooney, Max Lager, Maya M Davis, Megan A Haggerty, Michael F Skelly, PhD, Michael P Anthony, Michael P Sheehan, Michael P Sweeney, Michelle M Noe Varga, Nabil Nakhoul, Paraluman S Leonin, Paul P Geraci, Philip F Istafanos, DMV, MS, Philip Kreiter, Phillip E Mclaughlin, Ramon E Martinez, Richard H Penta, Robert J Martin, Robert O'brian, Rory K Geyer, Samuel K Mathew, Samuel Mathew, Sandra P White, Sara M Onyango, Sean R Marcsisin, Sherry M Nisson, Stacey S Degarmo, Sunita Pandey, Susanne M Richardson, MS RAC, Suzanne M Healy, Theresa M To, Thomas W Nerney, Victor J Gangi, Victoria M Daddeo

Constance Desimone's Documents

Publish Date Document Type Title
January, 2004 EIR Doe & Ingalls Inc. - EIR, 2004-01-27
January, 2000 EIR Lyne Laboratories, Inc. - EIR, 2000-01-19
August, 2000 EIR Parexel International Co. - EIR, 2000-08-23
August, 2003 EIR McLean Hospital Institutional Review Board - EIR, 2003-08-28
September, 2002 EIR TGA Sciences, Inc. - EIR, 2002-09-17
July, 2003 EIR Lyne Laboratories, Inc. - EIR, 2003-07-01
July, 2003 EIR Sunovion Pharmaceuticals Inc. - EIR, 2003-07-29
February, 2000 EIR Charles River Laboratories Preclinical Services - EIR, 2000-02-28
June, 2001 EIR Solvias USA, LLC - EIR, 2001-06-13
July, 2003 FDA 483 Response Sunovion Pharmaceuticals Inc. - Form 483R, 2003-08-07
August, 2000 FDA 483 Parexel International Co. - Form 483, 2000-08-23
November, 2005 EIR Bio-Concept Laboratories, Inc - EIR, 2005-11-18
April, 2000 FDA 483 Dr. Stanley Cheren, Cl. Clinical Studies Unit - Form 483, 2000-04-06
April, 2004 EIR Formatech Inc. - EIR, 2004-04-07
March, 2000 FDA 483 Lymol Medical Corporation - Form 483, 2000-03-09
July, 2002 EIR Thermo Fisher Scientific Inc. - EIR, 2002-07-10
April, 2000 EIR Stanley Cheren, M.D. - EIR, 2000-04-06
March, 2002 EIR Veranova, L.P. - EIR, 2002-03-11
April, 2002 EIR Solvias USA, LLC - EIR, 2002-04-02
April, 2002 FDA 483 New England Compounding Pharmacy, Inc. - Form 483, 2002-04-16
November, 2002 EIR Henry J. Crampton, MD - EIR, 2002-12-12
June, 2003 EIR Sunovion Pharmaceuticals Inc. - EIR, 2003-06-17
August, 2001 EIR Solvias USA, LLC - EIR, 2001-08-07

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more